In validation studies, genetic disruption of CaMKK2 expression or inhibition of its activity with small molecule inhibitors disrupted spontaneous metastatic outgrowth from primary tumors in murine xenograft models of TNBC.
[Cancer Research]
Home Newsletters Mammary Cell News Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly To Suppress Cancer Metastasis
